|

SHR-2173 Injection Clinical Trials

2 actively recruiting trials

▲ +1 trial since May 2026

Pipeline

Phase 2: 2

Top Sponsors

  • Guangdong Hengrui Pharmaceutical Co., Ltd2

Indications

  • Lupus2
  • Active Lupus Nephritis1
  • Systemic Lupus Erythematosus1

Other2 trials

A Phase II Clinical Study on the Efficacy and Safety of SHR-2173 Injection in the Treatment of Patients With Active Lupus Nephritis
Phase 2
A Study of SHR-2173 in Participants With Systemic Lupus Erythematosus
Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.